Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
3
43%
Ph phase_4
4
57%

Phase Distribution

3

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 4Post-market surveillance
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(3)

Detailed Status

Completed4
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (42.9%)
Phase 44 (57.1%)

Trials by Status

terminated114%
withdrawn229%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_1

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

NCT02743897
completedphase_1

Transplanting Hepatitis C Lungs Into Negative Lung Recipients

NCT03724149
completedphase_1

Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)

NCT03146741
withdrawnphase_4

A Prospective Cohort Study to Improve HCV Care in Dialysis Patients

NCT03791814
terminatedphase_4

The Dublin Zepatier Study

NCT02895958
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02743897Phase 1

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

Completed
NCT03724149Phase 1

Transplanting Hepatitis C Lungs Into Negative Lung Recipients

Completed
NCT03146741Phase 1

Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)

Completed
NCT03791814Phase 4

A Prospective Cohort Study to Improve HCV Care in Dialysis Patients

Withdrawn
NCT02895958Phase 4

The Dublin Zepatier Study

Terminated
NCT03093740Phase 4

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Withdrawn
NCT02781649Phase 4

Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7